| Connect Hearing, Inc. | |
|
1073 Ross Ave, Suite F, El Centro, CA 92243-4371 | |
| (760) 353-2525 | |
| (760) 353-5996 |
| Full Name | Connect Hearing, Inc. |
|---|---|
| Type | Facility |
| Speciality | Hearing Aid Equipment |
| Location | 1073 Ross Ave, El Centro, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376896993 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Connect Hearing, Inc. 750 N Commons Dr Ste 200, Aurora, IL 60504-7940 Ph: (630) 303-5380 | Connect Hearing, Inc. 1073 Ross Ave, Suite F, El Centro, CA 92243-4371 Ph: (760) 353-2525 |
News Archive
The Boston Scientific Corporation Vercise Deep Brain Stimulation System has received CE Mark approval for the treatment of intractable primary and secondary dystonia, a neurological movement disorder characterized by involuntary muscle contractions.
NanoString Technologies, Inc., a privately held life sciences company marketing a molecular barcoding detection system, today announced that the National Cancer Institute (NCI) is employing its nCounter™ Analysis System at two of its core labs.
Opexa Therapeutics, Inc., a company developing Tovaxin, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced that Neil K. Warma, Opexa's president and chief executive officer, will deliver a corporate presentation at Rodman & Renshaw's 11th Annual Healthcare Conference.
Taking daily supplements of fish or soy oil may improve cardiac function and protect against heart attacks in the short-term. Study results published in the April issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians, are the first to show that soy oil increases heart rate variability (HRV), a measure of cardiac autonomic function.
RTI Surgical Inc., a leading global surgical implant company, is launching two new biological solutions at the American Academy of Orthopaedic Surgeons annual meeting in New Orleans this week. NanOss Bioactive 3D, a synthetic three dimensional bioscaffold which supports bone formation, and map3™ Cellular Allogeneic Bone Graft, an implant that contains the three essential elements needed to generate and maintain new bone, will be introduced at the RTI Surgical exhibit at booth 5937 (Hall H) during the AAOS meeting.
› Verified 1 days ago